<DOC>
	<DOCNO>NCT01618747</DOCNO>
	<brief_summary>This single-arm , open-label , multicenter , observational study evaluate efficacy safety Avastin ( bevacizumab ) patient glioblastoma multiforme first second relapse . Data collect eligible patient initiated Avastin treatment accord local label 3 year .</brief_summary>
	<brief_title>An Observational Study Avastin ( Bevacizumab ) Patients With Glioblastoma Multiforme First Second Relapse</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Adults patient , &gt; /= 18 year age Histologically confirm glioblastoma multiforme first second relapse Patients qualify Avastin treatment per local label</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>